The International Prostate Symptom Score (IPSS), originally known as the American Urological Association Score, is the most commonly used scoring system for the quantification of benign prostatic hyperplasia symptoms. One area that has remained unexplored is the stability of the questionnaire construct be...
The International Prostate Symptom Score (IPSS) can be utilized to measure the severity of lower urinary tract symptoms. It is a validated, reproducible scoring system to assess disease severity and response to therapy. The IPSS is made up of 7 questions related to voiding symptoms. A score of...
The International Prostate Symptom Score (IPSS) can be utilized to measure the severity of lower urinary tract symptoms. It is a validated, reproducible scoring system to assess disease severity and response to therapy. The IPSS is made up of 7 questions related to voiding symptoms. A score of...
The Healthwise International Prostate Symptom Score is current as of February 10, 2021. Related Information Author Credentials:Ian was born and grew up in Australia. Since then, he has traveled and lived in numerous locations and currently resides in Montreal, Canada. Ian is the founder, a write...
International Prostate Symptom Score (IPSS) is a marker of lower urinary tract symptoms (LUTS) deterioration or improvement in benign prostate hyperplasia (BPH). Whereas changes in IPSS relative to baseline have been used as endpoints in clinical trials, little attention has been given to the time...
INTERNATIONALPROSTATESYMPTOMSCORE–IPSS-AUAASDISCRIMINATSCALEIN400MALEPATIENTSWITHLOWERURINARYTRACTSYMPTOMS(LUTS) PAULORODRIGUES,ALEXMELLER,JOÃOC.CAMPAGNARI,DANIELALCÂNTARA, MÁRCIOD’IMPÉRIO NeurourologyandVoidingSection,BeneficênciaPortuguesaHospital,andSantaHelenaHospital,SãoPaulo(SP)Brazil ...
网络国际前列腺症状评分;评分 网络释义
NSAIDs improved scores on the International Prostate Symptom Score (IPSS; P less than .001) and increased urine flow (0.89 mL/s; P = .01). What Matters: NSAIDs for benign prostatic hyperplasia Patients presenting with the lower urinary tract symptoms (LUTS) were interviewed on IPSS (Internat...
Introduction The aim of this study was to prospectively determine the value of pre-treatment International Prostate Symptom Score (IPSS) in predicting urinary morbidity after brachytherapy for organ-confined prostate cancer. Materials and Methods Between May 2002 and September 2008, we recorded pre-...
International Prostate Symptom ScoreOveractive bladder symptom scoreBiologically effective dosePSA bounceThe aim of this study was to evaluate the combined use of the overactive bladder symptom score (OABSS) and International Prostate Symptom Score (IPSS) as an assessment tool for urinary symptom flare...